You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 14, 2024

ETOMIDATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Etomidate

A generic version of ETOMIDATE was approved as etomidate by HIKMA on November 4th, 1996.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ETOMIDATE?
  • What are the global sales for ETOMIDATE?
  • What is Average Wholesale Price for ETOMIDATE?
Drug patent expirations by year for ETOMIDATE
Drug Prices for ETOMIDATE

See drug prices for ETOMIDATE

Recent Clinical Trials for ETOMIDATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ahon Pharmaceutical Co., Ltd.Phase 1
Hartford HospitalPhase 4
Jason ChuiPhase 4

See all ETOMIDATE clinical trials

Pharmacology for ETOMIDATE
Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Medical Subject Heading (MeSH) Categories for ETOMIDATE
Anatomical Therapeutic Chemical (ATC) Classes for ETOMIDATE

US Patents and Regulatory Information for ETOMIDATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avet Lifesciences ETOMIDATE etomidate INJECTABLE;INJECTION 204618-001 Aug 13, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma ETOMIDATE etomidate INJECTABLE;INJECTION 202354-001 Feb 25, 2016 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eugia Pharma ETOMIDATE etomidate INJECTABLE;INJECTION 206126-001 Feb 24, 2017 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.